Zantac and its generic form ranitidine have been voluntarily recalled due to the presence of NDMA (N-Nitrosodimethylamine) which is a probable carcinogen. The FDA is alerting both patients and health care providers of these recalls while also conducting additional testing to determine the levels of NDMA.
Generic ranitidine, sold under the popular brand name Zantac, is one of the most widely used antacids in the United States. Zantac, which can be prescribed or obtained over-the-counter, is a histamine-2 blocker that decreases the amount of acid in a patient’s stomach. As an H2 blocker, it is generally used as a heartburn medication associated with stomach acid indigestion. Zantac is also approved for the treatment and prevention of ulcers and gastroesophageal reflux disease.
What is NDMA?
NDMA is an organic chemical used in gasoline, rocket fuel, pesticides and fish processing as well as a lubricant additive and a stabilizer for industrial materials. In addition to Zantac and generic ranitidine medications, NDMA is also found in Valsartan and Losartan, two popular blood pressure medications.
The U.S. Food and Drug Administration (FDA, Environmental Protection Agency (EPA) and World Health Organization (WHO) have all classified NDMA as a carcinogen capable of causing cancer and agree that NDMA exposure increases cancer risk.
How was NDMA found in Zantac?
Valisure, an online pharmacy that conducted independent testing, found extremely high levels of NDMA, an active ingredient in Zantac, increasing the cancer risk for users of prescribed or over-the-counter antacids. Based on their findings, Valisure filed a Citizen Petition calling on the FDA to seek a market recall due to the significant risks associated with NDMA. It has been reported that the levels of NDMA are 3,000 to 26,000 times higher than the FDA allowable limit.
What are Your Legal Options?
There are currently individual lawsuits and class action lawsuits filed against the manufacturer of Zantac alleging they intentionally concealed risks and knowingly manufactured and sold ranitidine products containing a probable carcinogen to millions of people. Victims can also get justice through the Multi-District Litigation (MDL).
Multi-District Litigation (MDL) is a civil litigation process that consolidates individual lawsuits for a common product so that they can be litigated in a federal court. Unlike a class action lawsuit which is a single lawsuit filed by a large group of individuals suffering the same or similar harm, against a common defendant, MDLs involve multiple lawsuits filed by different individuals or groups of individuals. The goal of an MDL is to save the parties time and money by consolidating the discovery and pre-trial phase of litigation. Often parties to an MDL are encouraged to reach an agreeable resolution of the case through a global settlement.
Get a Free Case Evaluation
Lawyers Focused on Your Recovery
Thousands of Successful Cases in State and Federal Courts
Expertise in Dozens of Key Personal Injury Case Areas
The Zantac Multi-District Litigation
One of our Shareholders, Tracy Finken, has been appointed by the Honorable Robin Rosenberg of the United States District Court, Southern District of Florida as one of the Lead Counsel for the Zantac Multi-District Litigation (MDL). Finken will join a select group of attorneys from across the country who will spearhead the MDL’s leadership in the litigation of Zantac mass tort cases.
Anapol Weiss has been part of similar MDLs for pharmaceutical claims where billions in verdicts and settlements for victims were secured for victims, including $4.85 billion in the Merck & Co., Inc. Vioxx litigation, and $205 million in Pfizer’s Rezulin settlement.
Get a Free Consultation with Our Zantac Mass Torts Lawyers
If you were taking Zantac and developed cancer, our attorneys are available to discuss your potential claim. Lawsuits are often the only way for people to hold pharmaceutical companies accountable. The injury attorneys at Anapol Weiss will fight on your behalf for fair compensation. Call our office today for a free consultation.